Numerous partners of the CCHFVaccine project were actively involved in the 3rd International conference on CCHF that attracted researchers from across the globe.
The conference was held on 19th-21th September 2023 and featured presentations of high-caliber research, covering a wide spectrum of topics ranging from epidemiology and diagnostics to antiviral and vaccine development. You can explore the comprehensive program of the conference here.
At the same time, the CCHFVaccine project held its Excom meeting amid the conference, providing a valuable opportunity to deliberate on the forthcoming steps towards commencing a Phase 1 trial in Sweden. This trial is slated to begin in the first or second quarter of 2024.